StreetInsider.com News Articles

Form 11-K CARDINAL HEALTH INC For: Dec 31

Tue, 23 Jun 2026 08:22:00 -0400

si-local-file:///var/storage/secattach/20260623/26676363.html

Form 11-K CARDINAL HEALTH INC For: Dec 31

Tue, 23 Jun 2026 08:22:00 -0400

si-local-file:///var/storage/secattach/20260623/26676363.html

Form 11-K CARDINAL HEALTH INC For: Dec 31

Tue, 23 Jun 2026 08:21:00 -0400

si-local-file:///var/storage/secattach/20260623/26676357.html

Form 11-K CARDINAL HEALTH INC For: Dec 31

Tue, 23 Jun 2026 08:21:00 -0400

si-local-file:///var/storage/secattach/20260623/26676357.html

Form 144 CARDINAL HEALTH INC Filed by: KENNY GREGORY B

Mon, 08 Jun 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260608/26617148.html

Form 144 CARDINAL HEALTH INC Filed by: KENNY GREGORY B

Mon, 08 Jun 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260608/26617148.html

Form SD CARDINAL HEALTH INC

Mon, 01 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260601/26583504.html

Form SD CARDINAL HEALTH INC

Mon, 01 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260601/26583504.html

Cardinal Health (CAH) Declares $0.5158 Quarterly Dividend; 1% Yield

Tue, 05 May 2026 16:40:34 -0400

Cardinal Health (NYSE: CAH) declared a quarterly dividend of $0.5158 per share, or $2.0632 annualized.

The dividend will be payable on July 15, 2026, to stockholders of record on July 1, 2026, with an ex-dividend date of June 30, 2026.

The annual yield on the dividend is 1 percent.

For a dividend history and other dividend-related data on Cardinal Health (CAH) click here.

Cardinal Health Board of Directors Approves Quarterly Dividend

Tue, 05 May 2026 16:40:00 -0400

DUBLIN, Ohio, May 5, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend to $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2026 to shareholders of record at the close of business on July 1, 2026.

Cardinal Health Board of Directors Approves Quarterly Dividend

Tue, 05 May 2026 16:40:00 -0400

Cardinal Health Board of Directors Approves Quarterly Dividend

Tue, 05 May 2026 16:40:00 -0400

Cardinal Health Board of Directors Approves Quarterly Dividend

Tue, 05 May 2026 16:40:00 -0400

Cardinal Health (CAH) PT Lowered to $215 at JPMorgan

Mon, 04 May 2026 08:26:47 -0400

JPMorgan analyst Lisa Gill lowered the price target on Cardinal Health (NYSE: CAH) to $215.00 (from $243.00) while maintaining a Neutral rating.

Cardinal Health (CAH) PT Lowered to $248 at Baird

Fri, 01 May 2026 08:21:19 -0400

Baird analyst Eric Coldwell lowered the price target on Cardinal Health (NYSE: CAH) to $248.00 (from $257.00) while maintaining a Outperform rating.

Cardinal Health (CAH) PT Raised to $255 at TD Cowen

Fri, 01 May 2026 08:20:04 -0400

TD Cowen analyst Charles Rhyee raised the price target on Cardinal Health (NYSE: CAH) to $255.00 (from $251.00) while maintaining a Buy rating.

Cardinal Health (CAH) PT Lowered to $245 at Wells Fargo

Fri, 01 May 2026 07:53:55 -0400

Wells Fargo analyst Stephen Baxter lowered the price target on Cardinal Health (NYSE: CAH) to $245.00 (from $256.00) while maintaining a Overweight rating.

Cardinal Health (CAH) PT Lowered to $245 at Citi

Thu, 30 Apr 2026 15:51:32 -0400

Citi analyst Daniel Grosslight lowered the price target on Cardinal Health (NYSE: CAH) to $245.00 (from $249.00) while maintaining a Buy rating.

Cardinal Health (CAH) PT Lowered to $240 at BofA Securities

Thu, 30 Apr 2026 12:58:03 -0400

BofA Securities analyst Michael Cherny lowered the price target on Cardinal Health (NYSE: CAH) to $240.00 (from $260.00) while maintaining a Buy rating.

The analyst comments "Cardinal Health reported a mixed-to-positive FY3Q and raised FY26 EPS guidance, driven by below the line items and continued strength in the Pharma/Other segments (see our first take here). Importantly, $0.13 of the $0.50 midpoint adj. EPS increase is driven by operational strength in Pharma/Other which reinforces our confidence in sustained specialty momentum and core Pharma utilization heading into FY27. The guidance raise should also alleviate investor concerns around a potential moderation in industry growth.

Cardinal Health (CAH) PT Lowered to $240 at BofA Securities

Thu, 30 Apr 2026 12:58:03 -0400

BofA Securities analyst Michael Cherny lowered the price target on Cardinal Health (NYSE: CAH) to $240.00 (from $260.00) while maintaining a Buy rating.

Form 10-Q CARDINAL HEALTH INC For: Mar 31

Thu, 30 Apr 2026 08:54:00 -0400

si-local-file:///var/storage/secattach/20260430/26401718.html

Form 10-Q CARDINAL HEALTH INC For: Mar 31

Thu, 30 Apr 2026 08:54:00 -0400

si-local-file:///var/storage/secattach/20260430/26401718.html

Form 8-K CARDINAL HEALTH INC For: Apr 30

Thu, 30 Apr 2026 06:47:00 -0400

si-local-file:///var/storage/secattach/20260430/26400032.html

Form 8-K CARDINAL HEALTH INC For: Apr 30

Thu, 30 Apr 2026 06:47:00 -0400

si-local-file:///var/storage/secattach/20260430/26400032.html

Cardinal Health (CAH) Tops Q3 EPS by 38c; offers guidance

Thu, 30 Apr 2026 06:46:43 -0400

Cardinal Health (NYSE: CAH) reported Q3 EPS of $3.17, $0.38 better than the analyst estimate of $2.79. Revenue for the quarter came in at $60.9 billion versus the consensus estimate of $62.11 billion.

GUIDANCE:

Cardinal Health sees FY2026 EPS of $10.70-$10.80, versus the consensus of $10.31.

For earnings history and earnings-related data on Cardinal Health (CAH) click here.